arrow
Back
P

Patrick Verschueren

university hospital leuven and skeletal biology and engineering research center

36H-index
371Paper Count
6.8KCitation Count
Published Papers 96
Publication Date
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies
err2026-07-31
err0
errOAAI
errGerd R. Burmester; James Galloway; Karen Bevers; Jérôme Avouac; Susana Romero-Yuste; Roberto F. Caporali; Neil Betteridge; Carole Van der Donckt; Thomas P. A. Debray; Ouafia Tandjaoui Bouzid; Patrick Verschueren
errShare
errSave
Lung ultrasound for the detection of radiological progression of interstitial lung abnormalities in patients with rheumatoid arthritis
err2026-04-03
err0
PREAI
errMarie Vermant MD PhD; Valerie Van Ballaer MD; Joseph Jacob MD PhD; Tine Follet MD; Ryoko Egashira MD PhD; Kenny Anseele MD; Heleen Cypers MD; Laurens J. De Sadeleer MD PhD; Nico De Crem MD; Tinne Goos MD PhD; Barbara Neerinckx MD PhD; Veerle Taelman MD; Nathalie Veyt MD; Alexandros Kalkanis MD PhD; Patrick Verschueren MD PhD; Wim A. Wuyts MD PhD
errShare
errSave
The Patient-Reported Outcomes Measurement Information System scale v1.2 Global Health (PROMIS-GH) is useful to assess mental and physical health in individuals with chronic musculoskeletal pain, rheumatoid arthritis, hip/knee osteoarthritis, or people undergoing physiotherapy: Results of factor and item response theory analyses
err2025-10-20
err0
PREAI
errEmanuele M. Giusti; Leonardo Pellicciari; Martine H.P. Crins; Paul Dekker; Martin van der Esch; Marike van der Leeden; Willem F. Lems; Joost Dekker; Maarten Boers; Dirkjan van Schaardenburg; Johan Joly; Patrick Verschueren; Kristien Van der Elst; Rene Westhovens; Caroline B. Terwee; Leo D. Roorda
errShare
errSave
Mass spectrometry-based analysis of rheumatoid factor
err2025-10-10
err0
errOAAI
errJonas De Leeuw; Birthe Michiels; Rita Derua; Tom Dehaemers; Doreen Dillaerts; Maaike Cockx; Glynis Frans; Sebastien Christian Carpentier; Patrick Verschueren†; Xavier Bossuyt†
errShare
errSave
Long-term efficacy of filgotinib monotherapy and combination therapy: interim results from a post hoc analysis of the FINCH 4 study
err2025-04-28
err0
PREAI
errBuch, Maya; Verschueren, Patrick; Caporali, Roberto; Huizinga, Thomas; Omoruyi, Edmund; De Vries, Dick; Ritsema, Jeffrey; De Leonardis, Francesco; Aletaha, Daniel
errShare
errSave
ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung disease
err2025-04-01
err0
PREAI
errVulsteke, Jean-Baptiste; Lenaerts, Jan; Dillaerts, Doreen; Verschueren, Patrick; Wuyts, Wim A.; De Crem, Nico; De Sadeleer, Laurens; Vos, Robin; De Langhe, Ellen; Bossuyt, Xavier
errShare
errSave
Low apolipoprotein A1 and high apolipoprotein B levels indicate specific lipid changes in treatment naïve early psoriatic arthritis
err2025-01-08
err0
errOAAI
errIshchenko, Alla; Van Mechelen, M.; Storms, Lies; de Vlam, Kurt; Neerinckx, Barbara; Verschueren, P.
errShare
errSave
Thoracic ultrasound to detect interstitial lung disease associated with rheumatoid arthritis: comparing three protocols
err2024-10-30
err0
PREAI
errVermant, Marie; Kalkanis, Alexandros; Jacob, Joseph; Goos, Tinne; Cortesi, Emanuela Elsa; Cypers, Heleen; De Crem, Nico; Gogaert, Stefan; Neerinckx, Barbara; Taelman, Veerle; Veyt, Nathalie; De Sadeleer, Laurens J.; Verschueren, Patrick; Wuyts, Wim A.
errShare
errSave
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)
err2024-10-11
err0
errOAAI
errGeldof, Jeroen; Truyens, Marie; Sabino, Joao; Ferrante, Marc; Lambert, Jo; Lapeere, Hilde; Hillary, Tom; Van Laethem, An; de Vlam, Kurt; Verschueren, Patrick; Lobaton, Triana; Padalko, Elizaveta; Vermeire, Severine
errShare
errSave
Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study
err2024-06-07
err1
PREAI
errFierens, Liselotte; Coenen, Sofie; Joly, Johan; Vanhoutvin, Tine; De Dycker, Els; Bertrand, Delphine; Van Laer, Eva; Penny, Jens; Reumers, Jan; Verschueren, Patrick; De Haes, Petra; De Munter, Paul; Ferrante, Marc
errShare
errSave
THE PREDICTIVE POTENTIAL OF NOVEL ANTIBODY BIOMARKERS IN DETERMINING FIRST-LINE THERAPY RESPONSE IN RHEUMATOID ARTHRITIS
err2024-06-01
err0
PREAI
errFadlallah, S.; Vandormael, P.; Ruytinx, P.; Pues, A.; Sleurs, E.; Liesenborgs, J.; Joly, J.; Agten, A.; Vandenabeele, F.; Fraussen, J.; Verschueren, P.; Somers, V.
errShare
errSave
LONG-TERM EFFICACY OF FILGOTINIB MONOTHERAPY AND COMBINATION THERAPY: INTERIM RESULTS FROM A POST HOC ANALYSIS OF THE FINCH 4 STUDY
err2024-06-01
err1
PREAI
errBuch, M.; Verschueren, P.; Caporali, R. F.; Huizinga, T.; Omoruyi, E. V. Ekoka; De Vries, D.; Ritsema, J.; De Leonardis, F.; Aletaha, D.
errShare
errSave
EXPLORING POTENTIAL SCREENING TOOLS FOR INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS
err2024-06-01
err0
PREAI
errVermant, M.; Kalkanis, A.; Jacob, J.; Goos, T.; Cortesi, E. E.; Cypers, H.; De Crem, N.; Gogaert, S.; Neerinckx, B.; Taelman, V.; Veyt, N.; De Sadeleer, L.; Verschueren, P.; Wuyts, W.
errShare
errSave
THE PERCEPTIONS OF PATIENTS AND RHEUMATOLOGISTS ON THE CONCEPTS OF FLARE AND REMISSION IN RHEUMATOID ARTHRITIS: INDIVIDUAL SEMI-STRUCTURED INTERVIEWS STUDY
err2024-06-01
err0
PREAI
errDe Meyst, E.; Stroobants, R.; De Vroe, C.; Bertrand, D.; Doumen, M.; Van Elsacker, L.; Van Rompay, J.; Pazmino, S.; Westhovens, R.; Verschueren, P.
errShare
errSave
PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)TREATED WITH FILGOTINIB FOR UPTO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
err2024-06-01
err0
PREAI
errAvouac, J.; Burmester, G. R.; Caporali, R. F.; Debray, T. P. A.; De Leonardis, F.; Galloway, J.; Betteridge, N.; Bevers, K.; Romero-Yuste, S.; Zignani, M.; Verschueren, P.
errShare
errSave
EXPLORING THE DETERMINANTS OF THE JAKi BONUS IN REAL-WORLD OBSERVATIONAL DATA
err2024-06-01
err0
PREAI
errDiederik, D. C.; Durez, P.; Lenaerts, J.; Westhovens, R.; Verschueren, P.
errShare
errSave
REAL-WORLD EFFECTIVENESS OF UPADACITINIB ANDTNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS
err2024-06-01
err0
PREAI
errDiederik, D. C.; Durez, P.; Lenaerts, J.; Westhovens, R.; Verschueren, P.
errShare
errSave
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis
err2024-02-28
err2
errOAAI
errBertrand, Delphine; Deprez, Anke; Doumen, Michael; De Cock, Diederik; Pazmino, Sofia; Marchal, Anja; Thelissen, Marc; Joly, Johan; De Meyst, Elias; Neerinckx, Barbara; Westhovens, Rene; Verschueren, Patrick
errShare
errSave
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity
err2024-02-02
err1
errOAAI
errDillemans, Luna; Yu, Karen; De Zutter, Alexandra; Noppen, Sam; Gouwy, Mieke; Berghmans, Nele; Verhallen, Lisa; De Bondt, Mirre; Vanbrabant, Lotte; Brusselmans, Stef; Martens, Erik; Schols, Dominique; Verschueren, Patrick; Rosenkilde, Mette M.; Marques, Pedro Elias; Struyf, Sofie; Proost, Paul
errShare
errSave